אנסטרוזול מדיטק 1 מ"ג

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Principio attivo:

ANASTROZOLE 1 MG

Commercializzato da:

SAM-ON LTD

Codice ATC:

L02BG03

Forma farmaceutica:

FILM COATED TABLETS

Via di somministrazione:

PER OS

Prodotto da:

HELM PHARMACEUTICALS GMBH, GERMANY

Gruppo terapeutico:

ANASTROZOLE

Indicazioni terapeutiche:

Treatment of advanced breast cancer in post menopausal women. Efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. Adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. Adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.

Data dell'autorizzazione:

2011-01-01